STAT5A and neuroblastoma: CRISPR-Cas9-mediated STAT5A/B deletions were induced in a neuroblastoma cell line to determine the correlation of neuroprotective activity with the IFN-β/STAT5 pathway in neurodegenerative diseases such as Parkinson’s disease [65].